These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 2810071)

  • 1. Mean residence time for drugs subject to enterohepatic cycling.
    Shepard TA; Lockwood GF; Aarons LJ; Abrahams ID
    J Pharmacokinet Biopharm; 1989 Jun; 17(3):327-45. PubMed ID: 2810071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A recirculatory model with enterohepatic circulation by measuring portal and systemic blood concentration difference.
    Moriwaki T; Yasui H; Yamamoto A
    J Pharmacokinet Pharmacodyn; 2003 Apr; 30(2):119-44. PubMed ID: 12942684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An equation for the systemic availability of drugs undergoing simultaneous enterohepatic cycling, first-pass metabolism, and intestinal elimination.
    Shepard TA; Reuning RH
    Pharm Res; 1987 Jun; 4(3):195-9. PubMed ID: 3509282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Gallbladder-Based Enterohepatic Circulation Model for Pharmacokinetic Studies.
    Okour M; Brundage RC
    Eur J Drug Metab Pharmacokinet; 2019 Aug; 44(4):493-504. PubMed ID: 30488336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An experimental design strategy for quantitating complex pharmacokinetic models: enterohepatic circulation with time-varying gallbladder emptying as an example.
    Wang YM; Reuning RH
    Pharm Res; 1992 Feb; 9(2):169-77. PubMed ID: 1553336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A quantitative enterohepatic circulation model: development and evaluation with tesofensine and meloxicam.
    Lehr T; Staab A; Tillmann C; Trommeshauser D; Schaefer HG; Kloft C
    Clin Pharmacokinet; 2009; 48(8):529-42. PubMed ID: 19705923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Model-Based Prediction of Plasma Concentration and Enterohepatic Circulation of Total Bile Acids in Humans.
    Guiastrennec B; Sonne DP; Bergstrand M; Vilsbøll T; Knop FK; Karlsson MO
    CPT Pharmacometrics Syst Pharmacol; 2018 Sep; 7(9):603-612. PubMed ID: 30070437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficiency of enterohepatic circulation, its determination and influence on drug bioavailability.
    Horkovics-Kovats S
    Arzneimittelforschung; 1999 Oct; 49(10):805-15. PubMed ID: 10554656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Description and simulation of a physiological pharmacokinetic model for the metabolism and enterohepatic circulation of bile acids in man. Cholic acid in healthy man.
    Hofmann AF; Molino G; Milanese M; Belforte G
    J Clin Invest; 1983 Apr; 71(4):1003-22. PubMed ID: 6682120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interpretation of area under the curve measurements for drugs subject to enterohepatic cycling.
    Shepard TA; Reuning RH; Aarons LJ
    J Pharm Sci; 1985 Feb; 74(2):227-8. PubMed ID: 3989699
    [No Abstract]   [Full Text] [Related]  

  • 11. Estimation of area under the curve for drugs subject to enterohepatic cycling.
    Shepard TA; Reuning RH; Aarons LJ
    J Pharmacokinet Biopharm; 1985 Dec; 13(6):589-608. PubMed ID: 3834073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism-based enterohepatic circulation model of mycophenolic acid and its glucuronide metabolite: assessment of impact of cyclosporine dose in Asian renal transplant patients.
    Yau WP; Vathsala A; Lou HX; Zhou S; Chan E
    J Clin Pharmacol; 2009 Jun; 49(6):684-99. PubMed ID: 19386625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Model systems for pharmacokinetics of steroid drugs subject to enterohepatic circulation.
    Schumann W; Hillesheim HG; Gira G
    Exp Clin Endocrinol; 1986 Jul; 87(2):118-24. PubMed ID: 3758191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accumulation and time to steady state for drugs subject to enterohepatic cycling: a stimulation study.
    Shepard TA; Gannaway DJ; Lockwood GF
    J Pharm Sci; 1985 Dec; 74(12):1331-3. PubMed ID: 4087202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of mean residence-time concepts to pharmacokinetic systems with noninstantaneous input and nonlinear elimination.
    Cheng HY; Jusko WJ
    Pharm Res; 1989 Jan; 6(1):4-12. PubMed ID: 2717515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enterohepatic circulation: physiological, pharmacokinetic and clinical implications.
    Roberts MS; Magnusson BM; Burczynski FJ; Weiss M
    Clin Pharmacokinet; 2002; 41(10):751-90. PubMed ID: 12162761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The application of sample pooling methods for determining AUC, AUMC and mean residence times in pharmacokinetic studies.
    Cheung BW; Cartier LL; Russlie HQ; Sawchuk RJ
    Fundam Clin Pharmacol; 2005 Jun; 19(3):347-54. PubMed ID: 15910659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mycophenolic Acid and Its Metabolites in Kidney Transplant Recipients: A Semimechanistic Enterohepatic Circulation Model to Improve Estimating Exposure.
    Okour M; Jacobson PA; Ahmed MA; Israni AK; Brundage RC
    J Clin Pharmacol; 2018 May; 58(5):628-639. PubMed ID: 29329489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Population pharmacokinetic modelling of the enterohepatic recirculation of diclofenac and rofecoxib in rats.
    Huntjens DR; Strougo A; Chain A; Metcalf A; Summerfield S; Spalding DJ; Danhof M; Della Pasqua O
    Br J Pharmacol; 2008 Mar; 153(5):1072-84. PubMed ID: 18193075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. On the population pharmacokinetics and the enterohepatic recirculation of total ezetimibe.
    Soulele K; Karalis V
    Xenobiotica; 2019 Apr; 49(4):446-456. PubMed ID: 29629619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.